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Predictors of Shared Decision Making and Level of Agreement between Consumers and Providers in Psychiatric 
Care 
Abstract 
The purpose of this study was to quantitatively examine elements of shared decision making (SDM), and to establish 
empirical evidence for factors correlated with SDM and the level of agreement between consumer and provider in 
psychiatric care. Transcripts containing 128 audio-recorded medication check-up visits with eight providers at three 
community mental health centers were rated using the Shared Decision Making scale, adapted from Braddock’s 
Informed Decision Making Scale (Braddock et al., 1997; 1999; 2008). Multilevel regression analyses revealed that 
greater consumer activity in the session and greater decision complexity significantly predicted the SDM score. The 
best predictor of agreement between consumer and provider was “exploration of consumer preference,” with a four-
fold increase in full agreement when consumer preferences were discussed more completely. Enhancing active 
consumer participation, particularly by incorporating consumer preferences in the decision making process appears 
to be an important factor in SDM.  
Introduction 
Shared decision-making (SDM) has been the object of increased interest in mental health care.  SDM is 
defined as “an interactive process in which physicians and patients simultaneously participate in all phases of the 
decision-making process and together negotiate a treatment to implement” (Charles et al., 2003). Implementation of 
SDM is consistent with the Institute of Medicine’s call for person-centered care that accounts for the needs, 
preferences, and satisfaction of people with mental illness (Institute of Medicine, 2006).  
Several studies address potential barriers to SDM in psychiatric care. For example, concerns about 
decisional capabilities (Drake, Cimpean, & Torrey, 2009; Hamann, Mendel, Reiter et al., 2011), providers’ 
paternalistic views (Hamann, Mendel, Bühne et al., 2011; Young et al., 2008), and time constraints (Torrey & Drake, 
2010) have all been identified as possible barriers to SDM in psychiatric care. Some studies also show variations in 
SDM based on consumer and provider characteristics. For example, Young et al. (2008) found that older providers 
used less SDM with consumers in depression care. Providers’ clinical experience and available resources have also 
been found to influence decision making (Bhugra et al., 2011).With regard to consumer characteristics, providers of 
psychiatric services reported being more likely to use SDM for consumers who were more adherent to treatment and 
had higher educational levels (Hamann et al., 2009). Trust and confidence in consumers’ own decisional capacities 
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and consumers’ concerns about medications are also related to SDM preference (Hamann, Mendel, Bühne et al., 
2011; Hamann, Mendel, Reiter et al., 2011). In addition, racial and ethnic disparities in SDM have been investigated 
(Alegria et al., 2008; Whitney, McGuire, & McCullough, 2004). Further, in research from somatic medicine, Say et 
al. (2006) reported that demographics, including age, gender, and socio-economic status, play an important role in 
medical decision making. For example, consumers who were younger and more educated showed a higher 
preference for involvement (Thompson, Pitts, & Schwankovsky, 1993), but not consumers who presented with more 
severe illness (Arora & McHorney, 2000; Say, Murtagh, & Thomson, 2006). Women (Arora & McHorney, 2000) 
and Caucasians (Murray et al., 2007) appear to want more involvement compared to their counterparts.  
In addition, some studies discuss potential variations in SDM in terms of decisional and interactional 
characteristics. For example, Braddock et al. (1999) and Whitney et al. (2004) argue that as the complexity of the 
decision increases, the need for SDM becomes greater.  Elwyn et al. (2005), however, have argued that all decisions 
should be shared, regardless of level of complexity.  Given the limited length of an office visit (Drake, Cimpean, & 
Torrey, 2009;  Torrey & Drake, 2010), time factors could also affect SDM practice.  Further, the importance of 
consumers’ active participation in medical appointments has been discussed (Alegria et al., 2009;  Salyers et al., 
2009). For example, with greater consumer involvement in discussion (e.g., initiating discussion about treatment, 
making a request for medication), providers are more likely to use SDM (Young et al., 2008).  Thus, decisional and 
interactional characteristics may be important factors to consider when examining the degree to which SDM is 
taking place.  
Ultimately SDM potentially reduces decisional conflicts (Fraenkel & McGraw, 2007; Stewart, 1995), 
resulting in a higher level of agreement between consumer and provider. Engaging the consumer in the decision 
making process should result in better agreement (Hamann et al., 2008; 2009). Thus, successful SDM, in which the 
core elements of the decision are discussed thoroughly between consumers and providers, should predict the level of 
agreement between consumer and provider.   
Study Purpose 
Few studies have empirically examined facilitators of SDM in psychiatric care.   Moreover, such studies 
have relied on self-report, which is more prone to bias than observation. As a result, we know very little about how 
consumer and provider characteristics are associated with shared decision making in actual mental health practice.  
Even less is known about how interactional factors, in the conversation itself, may influence decision making and 
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agreement.  This exploratory study was a secondary analysis of pre-existing audio-recorded psychiatric visit datasets. 
With the available information, we explored the potential role of consumer characteristics (i.e., age, gender, race, 
diagnosis), provider characteristics (i.e., gender, provider type, study site), decision characteristics (i.e., complexity), 
and interactional factors (i.e., length of the visit, level of consumer involvement). We hypothesized that as 
consumers participate more in an office visit, SDM will be higher. Further, the more thoroughly the core elements of 
the decision are discussed, the more likely consumers and providers are to reach full agreement about the 
consumer’s treatment.  Some of prior work has examined qualitative descriptions of how decisions are made in 
psychiatric consultations (Bhugra, Easter, Mallaris et al., 2011; Goscha, 2009; Matthias, Salyers, Rollins et al., 
2012).  Recently, we have adapted a tool to measure shared decision making (Salyers, Matthias, Fukui et al., 2012) 
and were interested in better understanding what factors were associated with higher scores and level of agreement 
as rated on this scale. 
Method 
Study Participants 
This was a retrospective study of audio-recorded psychiatric visits at three community mental health 
centers. Data sources used in this study were collected separately for another purpose and included: 1) an 
observational study of 40 psychiatric visits (4 providers, with 10 consumers each) (Salyers et al., 2009); 2) a 
baseline assessment in a randomized control trial of CommonGround, an intervention to improve SDM (3 providers 
and 98 consumers) (Deegan et al., 2008); and 3) an observational study of 48 psychiatric visits with one provider. 
All audio-recordings were transcribed and checked for accuracy. In total, the transcripts included eight providers and 
186 adult consumers of the community support services. Because of technical difficulties with 16 audio-recordings, 
170 consumers had audio-recordings available. Forty two (25%) of the 170 transcripts did not contain any clinical 
decisions (i.e., discussion with an explicit course of action); rather, these were predominately check-in visits 
concerning the consumer’s progress.  If there was no explicit conversation to keep treatment the same, or change the 
course of treatment, elements of SDM were not coded. The remaining 128 transcripts were included in the analyses.  
Socio-demographic characteristics of consumers were obtained from their providers at one site. For the two 
remaining sites, the information was obtained from a statewide Automated Information Management Systems 
(Kansas Department of Social and Rehabilitation Services, 2005).  Consumers’ characteristics are shown in Table 1. 
Five providers were psychiatrists and three were nurse practitioners. Half of the providers were male and half were 
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female. Other providers’ characteristics such as age, race, and length of practice experience were not available in the 
original datasets. Written informed consent approved by the Institutional Review Boards of both the University of 
Kansas and Indiana University-Purdue University Indianapolis was obtained from all participants.   
Insert Table 1 around here 
Shared Decision Making Scale  
The Shared Decision Making (SDM) Scale, adapted from Braddock’s Informed Decision Making Scale 
(Braddock et al., 1997; 1999; 2008), was used to characterize the decision making process between providers and 
consumers in psychiatric visits (Salyers et al., 2012). Braddock’s coding system has shown high reliability in several 
studies of decision making with primary care physicians and surgeons (Braddock et al., 1997; 1999; 2008; Ling et 
al., 2008).  The scale consists of nine elements of shared decision making: 1) consumer role in decision making, 2) 
consumer goal / context of decision, 3) clinical issue or nature of the decision, 4) alternative options, 5) pros and 
cons of the alternatives, 6) uncertainties associated with the decision, 7) assessing consumer understanding, 8) 
assessing consumer desire for others’ input, and 9) exploration of consumer preference. The thoroughness of the 
discussion for each of the nine elements was evaluated using three categories (Absent=0, Partial=1, Complete=2). 
Following Braddock et al.’s (1999) scoring method, items were summed for an overall SDM score ranging from 0 to 
18. The initiator of the discussion (Consumer=1, Provider=0) of each element was also identified. We calculated a 
sum of the scores indicating whether the consumer initiated each element, ranging from 0 to 9 to serve as a proxy for 
how active a consumer was in the session. Each transcript with a decision was classified by decision complexity 
(Basic=1, Intermediate=2, Complex=3) based on the extent to which the treatment decision’s consequence could 
affect the consumer’s life and the level of medical consensus available. Basic decisions have high medical consensus 
and pose little risk to the consumer (e.g., timing of medication dose).  Complex decisions have uncertain outcomes 
or high controversy in the literature and may have extensive impact on a consumer (e.g., starting a new prescription 
of clozapine).  Intermediate decisions fell in between in terms of medical consensus and impact on consumer (e.g., 
starting a new antipsychotic other than clozapine). Given the frequencies observed in this study (basic [n=59, 46%], 
intermediate [n=67, 52%], and complex [n=2, 2%]), decision complexity was re-categorized into basic [=0] and 
either intermediate or complex [=1].  The level of final agreement of the decision between consumer and provider 
was also rated (i.e., full agreement of both parties, passive/reluctant agreement by consumer or provider, 
disagreement by consumer or provider). We examined full agreement [=1] versus all others–lack of full agreement 
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[=0] in this study. Transcripts were scored by trained raters.  After the initial training, five raters divided the 
transcripts, scoring every fourth transcript in common to maintain reliability throughout the study.  Sufficient inter-
rater reliability among three raters for the SDM scale was confirmed by the AC1 statistic (.51–.97), which is favored 
over Kappa statistic for multiple raters and multiple responses because it adjusts for chance agreement and 
misclassification errors (Gwet, 2010). 
Data Analyses 
Our first set of analyses predicted the overall level of SDM (total score).  A multilevel linear regression 
analysis was conducted to examine how length of visit (minutes), decision complexity (basic =0 vs. 
intermediate/complex =1), and the consumer initiator score predicted the SDM score. Consumer characteristics (i.e., 
age, gender, race, schizophrenia spectrum) [a level-one unit] and provider characteristics (i.e., provider type [nurse 
practitioner = 0, MD = 1], gender, study site) [a level-two unit] were also included. SAS PROC MIXED was used 
for the multilevel linear regression analysis. The second analysis was to predict level of agreement between the 
provider and consumer.  We conducted a multilevel binary logistic regression analysis to examine how the 
thoroughness of the discussion for each of the nine elements (Absent [=0], Partial [=1], Complete [=2]), length of 
visit, decision complexity, and the consumer initiator score predicted full agreement with the decision (Full 
agreement [=1] vs. Lack of full agreement [=0]). Both consumer and provider characteristics were also included. 
SAS PROC GLIMIX was used for the multilevel logistic regression analysis. The explained variance for the 
regression models was calculated using the formula in Snijders and Bosker (1999).  
 In this study, multilevel modeling was used to account for the clustered data structure where consumers are 
nested within providers. That is, consumers meeting with the same provider may share similar experiences 
compared to consumers who are meeting with the other providers. This sample dependency biases estimates of 
standard errors when examining the effects of providers. Given the nature of current clustered data, multilevel 
modeling is favored for correcting for the biased standard errors. 
Results 
Mean SDM score was 9.7 (SD=3.3) on a scale from 0-18; consumer initiator score was 1.8 (SD=1.5) on a 
0-9 scale; and mean length of visit was 16.7 minutes (SD=7.0). Fifty nine participants (46%) had a “basic” decision 
and 69 (54%) had either an “intermediate or complex” decision. Examples of decisions by their complexity are 
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included in Table 2. Full agreement (both provider and consumer agreed) was achieved in 101 (79%) decisions, 
while 27 (21%) decisions included some disagreement by either consumer or provider.  
Multilevel linear regression analysis revealed that the consumer initiator score (β=0.767, p<.001) and 
decision complexity (β=2.467, p<.001) were significant factors predicting SDM score (Table 3). That is, greater 
levels of shared decision making were observed when decisions were more complex and when consumers initiated 
more of the elements. Together these variables explained 37.6% of the variance in overall SDM score at consumer-
level (a level-one unit). 
Multilevel logistic regression analysis predicting overall full agreement (Table 4) showed that 
incorporating consumer preference in discussion is an important factor. The likelihood of full agreement was four 
times higher when “exploration of consumer preference” (β=1.379, p<.01, OR=3.97) was discussed more 
completely. This was the only significant predictor of level of agreement. This element accounted for 52.5% of the 
variance in full agreement at consumer-level (a level-one unit). For both of the multilevel models, the variances of 
random intercepts (in-between level variance) were not significant, indicating the outcomes did not vary across 
providers. 
Insert Table 2, 3, 4 around here 
Discussion 
This is the first study we are aware of that uses actual clinical interactions to examine factors associated 
with shared decision making in psychiatric visits.  Moreover, this is the first study that examines clinical interactions 
to identify elements of the interaction itself that appear to be conducive to shared decision making and level of 
agreement in clinical decisions. Overall, the average SDM score was just above the theoretical midpoint, indicating 
a modest degree of utilization of all elements of shared decision making. Despite not using all the elements of SDM, 
the majority of decisions had agreement between consumer and provider (79%). 
We found that the available demographic characteristics of consumers (i.e., age, gender, race, 
schizophrenia spectrum) and providers (i.e., provider type [nurse practitioner or MD], gender) were not significantly 
related to SDM scores.  While the role of consumer demographics has been identified as important to medical 
decision making (Say et al., 2006), these studies often relied on self-report predicting preference for decision making, 
rather than actual observed behavior.  As others have noted discrepancies between consumers’ preferences and 
actual participation during decision making (Tariman et al., 2010), it may be that demographics are more closely 
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related to preferences than actual behavior. In mental health, some demographics such as low levels of education 
and minority status may be potential challenges for SDM (Hamann et al., 2009; Alegria et al., 2008). The mental 
health literature on the association between consumer demographics and stated or observed SDM is sparse.   
Regarding provider characteristics, Young et al (2008) found that age was significantly related to SDM performance 
but not other demographics, including race and gender. However, information on providers’ age was not available in 
our study because the original datasets combined for this study were collected for another purpose and did not 
include the information. Further research is needed on the role of provider and consumer characteristics in shared 
decision making in mental health contexts. 
Our study revealed that decision complexity and consumers’ initiation of the discussions (i.e., level of 
involvement) have more impact on SDM scores than demographic characteristics of the providers and consumers. 
Further, although SDM has been associated with longer clinic visits (Young et al., 2008), we did not find this 
relationship.  In other analyses (Salyers et al., 2012), we found that controlling for complexity, SDM was not related 
to length of visit. Complexity as a predictor of SDM is consistent with arguments by Braddock et al. (1999) and 
Whitney et al. (2004) that decision complexity drives the need for shared decision making. Bhugra et al. (2011) also 
found that decisions were dependent on the level of risk and uncertainty.  That is, more complex decisions should 
involve more elements of SDM than basic decisions.  
We found consumer initiative was associated with greater SDM scores.  Consumer initiation was a code 
that was added to the Braddock scale (Salyers et al., 2012), so we cannot compare our findings directly with prior 
work on SDM using this scale.  However, consumer initiation is consistent with Young et al.’s study (2008), which 
found that greater consumer involvement in discussion was related to higher SDM observed by the revised 
Observing Patient Involvement scale. The importance of the consumer’s active participation in the decision making 
process has been emphasized previously and interventions have been designed to increase participation (Alegria et 
al., 2009; Deegan & Drake, 2006; Salyers et al., 2009). However, it should be noted that some researchers have 
suggested that active involvement (i.e., insistence of own preferences, doubt about providers’ recommendation) 
could threaten providers, especially when providers feel challenged by consumer’s questions and tend towards a 
paternalistic role (Alegria et al., 2008; Hamann, Mendel, & Bühner et al., 2011). It is likely that both consumers and 
providers may benefit from coaching on how to effectively communicate preferences and how to effectively 
incorporate them. In a qualitative study analyzing a subset of the transcripts in the current study, Matthias et al. 
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(2012) found that even though providers frequently initiated a discussion of a decision, they often did ask for the 
consumer’s input. Similarly, Legare et al. (2012) indicated that without providers explicitly asking for consumers’ 
preferences, these preferences may or may not be incorporated. Full integration of SDM will require environments 
that support both consumers to be active and providers to be receptive to this active role.   
In terms of overall agreement between consumers and providers, the only significant predictor was 
discussion of consumer preference. A thorough discussion of consumer preference increased the likelihood of final 
agreement by four times when holding other predictors constant. Interestingly, no association was found for other 
important elements of SDM, including discussions about treatment options (i.e., clinical issue, alternatives, pros and 
cons, uncertainties, understanding, other’s input). However, the results may not be surprising when considering the 
findings of Woltmann and Whitley (2010), who studied agreement /disagreement between consumers and case 
managers in decision making. They revealed that consumers tend to focus on their own decision-making limitations 
or issues related to the decision itself when they have disagreement. However, when there is agreement, consumers 
focus on the relationship and affective aspects of decision making rather than on the deliberative process or the 
contents of the decision (Woltmann & Whitley, 2010).  A thorough discussion of consumer’s preference may 
support consumers’ sense of autonomy in the decision making process, which may increase the agreement level.  
Without discussion, providers will not be able to access consumer preferences. Providers need direct assessment 
since, without it, they can be inaccurate in perceiving the preferences of the consumer (Strull, Lo, & Charles, 1984). 
This may be particularly important for shared decision making in psychiatric care, given the concerns that 
psychiatrists often underestimate the consumers’ decisional capacity and preference regarding medication (Drake et 
al, 2009) and that some consumers may not believe that they have the ability to make their own choices (Puschner et 
al. 2010). 
Some limitations of this study need to be acknowledged. First, the study took place at only three agencies, 
using a convenience sample at two of the sites.  This limits the generalizability of the study results. Second, this was 
a cross-sectional study that lacks temporal information, including the length of relationship and the consequences of 
observed decisions. The association between consumer characteristics and SDM may be mediated by the 
relationship between the consumer and provider (Arora & McHorney, 2000). Longitudinal studies will be needed to 
examine the causality among variables as well as the consequential actions the consumers may take after the final 
decision. Third, because we analyzed data from previous studies, we were limited in our ability to examine provider 
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and consumer characteristics. We obtained satisfactory amounts of explained variances in our predictive models for 
an initial study, but other important variables could be missing. Previous work on decision making in mental health 
care suggests, for example, that older providers might be more likely to be paternalistic (Hamann et al., 2009; 
Young et al., 2008). Fourth, we lacked power to find provider-level differences.  For multilevel modeling, the 
effective sample size for the between-level effect is only eight (8 providers), which leads to a lack of power to detect 
a nonzero effect in between-level units.  Fifth, the majority (79% vs. 21%) of decisions were characterized by “full 
agreement,” based on the information available in the transcript. The imbalance in cell sizes may have affected our 
ability to detect significant predictors. Finally, although we used trained raters, the same raters coded many of the 
variables at the same time (complexity of decision, elements of SDM, and overall agreement).  This could lead to 
inflation of correlations due to common method variance. Despite the limitations, however, our study reinforced that 
enhancing active consumer participation, particularly by incorporating consumer preferences in the decision making 
process appears to be an important factor in mental health SDM. 	  	   
Conclusions 
This study aimed to establish empirical evidence demonstrating factors facilitating SDM and the level of 
agreement between consumers and providers in psychiatric care. Our findings revealed that decision complexity 
predicted a higher level of SDM. In addition, consumer involvement enhances SDM and overall agreement. Given 
the inevitable power structure that exists between provider and consumer, the provider’s expectation and 
encouragement of the consumer’s involvement should enhance SDM. Further study will be needed to build more 
evidence in this emerging area, incorporating longitudinal and experimental designs.  
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Table 1  
Descriptive information on consumers’ characteristics and  
shared decision making (N=128) 
  n % 
Age M=43.4 SD=10.63 
Gender   
     Male 63 49.2 
     Female 65 50.8 
Race   
    White / Caucasian 65 51.2 
    African American 56 44.1 
    Other 6 4.7 
Diagnosis   
     Schizophrenia 72 56.3 
     Bipolar 18 14.1 
     Major depression 30 23.4 
     Other 8 6.3 
Decision Complexity   
     Basic 59 46.1 
     Intermediate  67 52.3 
     Complex 2 1.6 
Agreement Level   
     Provider disagree / reluctant agree 8 6.3 
     Full agreement (both agree) 101 78.9 
     Consumer reluctant agree 19 14.8 
Length of visit M=16.75 SD=6.96 
SDM score M=9.73 SD=3.27 
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Table 2 
 
Decision examples by the complexity 
 
Note:  More than one topic of decision may have appeared in the same discussion due to their highly 
related nature (e.g., adding a new medication and decreasing one medication at the same time to address a 
symptom), so the final coding of the decision complexity was based on the overall discussion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Topic of Decision Basic Intermediate/Complex 
Stopped a medication n/a 
Stop Medication B because consumer 
is taking Medication A that also 
helps sleep 
Added a medication Add Vitamin E Decided to use Medication C for weight loss 
Dosage change Decrease medication A (doing well and has decreased in past) 
Increase Medication A for 
hallucinations 
Decided not to change medication Continue medications as prescribed Start another medication, and keep this medication the same 
Non-medication alternative 
Continue to go to church to make 
more social connections and leave 
medications the same 
Discussion of different ways to 
address high cholesterol 
Change time or change way of taking 
currently prescribed medication or  
restart previous medication 
Take medication one hour later 
because of sleepiness 
Deciding whether to restart 
previously described medications and 
if so, which ones 
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Table 3  
Multilevel linear regression analysis predicting SDM score 
 β SE z p 
Level-one predictors 
Age -0.007 0.022 -0.330 0.743 
Gender 0.118 0.476 0.250 0.805 
White 0.013 0.517 0.030 0.980 
Schizophrenia spectrum 0.610 0.512 1.190 0.237 
Consumer initiator score 0.767 0.159 4.840 <.001*** 
Length of visit 0.055 0.043 1.280 0.204 
Decision complexity 2.467 0.466 5.290 <.001*** 
Level-two predictors 
MD -2.762 1.910 -1.450 0.151 
Male Doc 1.838 1.755 1.050 0.297 
Site 1 (dummy1) 0.866 1.510 0.570 0.568 
Site 2 (dummy2) 2.499 1.617 1.550 0.125 
Intercept 4.545 2.073 2.190 0.116 
Intercept variance 1.002 1.490 0.670 0.251 
*** p<.001 
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Table 4  
Multilevel binary logistic regression analysis predicting full agreement 
  β SE t p OR 
Level-one predictors 
     Demographics 
        Age 0.022 0.031 0.720 0.474 1.023 
   Gender 0.552 0.697 0.790 0.431 1.736 
   White 0.851 0.765 1.110 0.269 2.342 
   Schizophrenia spectrum -0.434 0.750 -0.580 0.564 0.648 
Decision Characteristic and Interactional Factors 
     Decision complexity -1.251 0.788 -1.590 0.115 0.286 
   Lengths of visit -0.040 0.062 -0.650 0.516 0.960 
   Consumer initiator score 0.362 0.236 1.540 0.127 1.437 
Thoroughness of discussion in 9 elements 
      Consumer's role -0.624 0.519 -1.200 0.232 0.536 
   Goal / Context 0.525 0.910 0.580 0.565 1.691 
   Clinical issue -0.887 0.588 -1.510 0.134 0.412 
   Alternatives -0.719 0.708 -1.020 0.312 0.487 
   Pros and cons -0.652 0.549 -1.190 0.238 0.521 
   Uncertainties 0.640 0.484 1.320 0.189 1.897 
   Understanding 0.032 0.561 0.060 0.955 1.032 
   Other's input -0.924 0.587 -1.570 0.118 0.400 
   Preference 1.379 0.480 2.870 <.01** 3.969 
Level-two predictors 
     MD -3.673 1.949 -1. 890 0.102 0.025 
Male Doc 1.856 1.747 1.060 0.322 6.400 
Site 1 (dummy 1) 0.209 1.425 0.150 0.892 1.232 
Site 2 (dummy 2) 1.188 1.647 0.720 0.512 3.279 
      Intercept 1.651 3.165 0.520 0.605 – 
Intercept variance 0.497 1.118 0.445 0.656 – 
** p<.01 
 
 
	  
	  
	  
	  
	  
